BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shaker MK, Abdel Fattah HI, Sabbour GS, Montasser IF, Abdelhakam SM, El Hadidy E, Yousry R, El Dorry AK. Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients. World J Hepatol 2017; 9(9): 469-476 [PMID: 28396717 DOI: 10.4254/wjh.v9.i9.469] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Wang T, Wang Z, Niu R, Wang L. Crucial role of Anxa2 in cancer progression: highlights on its novel regulatory mechanism. Cancer Biol Med 2019;16:671-87. [PMID: 31908887 DOI: 10.20892/j.issn.2095-3941.2019.0228] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
2 Siracusano G, Tagliamonte M, Buonaguro L, Lopalco L. Cell Surface Proteins in Hepatocellular Carcinoma: From Bench to Bedside. Vaccines (Basel) 2020;8:E41. [PMID: 31991677 DOI: 10.3390/vaccines8010041] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Sun J, Li B, Sun A, Zhao K, Ma Y, Zhao J, Pan H, Song Q, Wang Y, Yu C, Wang C, Zhang H, Zhang W, Kong C. Comprehensive analysis of aberrantly expressed profiles of messenger RNA in alcoholic liver disease. J Cell Biochem 2019;120:4248-54. [PMID: 30294942 DOI: 10.1002/jcb.27710] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Amhimmid Badr S, Waheeb Fahmi M, Mahmoud Nomir M, Mohammad El-Shishtawy M. Calcium channel α2δ1 subunit as a novel biomarker for diagnosis of hepatocellular carcinoma. Cancer Biol Med 2018;15:52-60. [PMID: 29545968 DOI: 10.20892/j.issn.2095-3941.2017.0167] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
5 Wang X, Yu T, Liao X, Yang C, Han C, Zhu G, Huang K, Yu L, Qin W, Su H, Liu X, Peng T. The prognostic value of CYP2C subfamily genes in hepatocellular carcinoma. Cancer Med 2018;7:966-80. [PMID: 29479826 DOI: 10.1002/cam4.1299] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
6 Farag RMA, Al Ayobi D, Alsaleh KA, Kwon HJ, EL-Ansary A, Dawoud EA. Studying the Impact of Golgi Protein 73 Serving as a Candidate Biomarker in Early Diagnosis for Hepatocellular Carcinoma among Saudi Patients. Asian Pac J Cancer Prev 2019;20:215-20. [PMID: 30678434 DOI: 10.31557/APJCP.2019.20.1.215] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Li Z, Yu L, Hu B, Chen L, Jv M, Wang L, Zhou C, Wei M, Zhao L. Advances in cancer treatment: a new therapeutic target, Annexin A2. J Cancer 2021;12:3587-96. [PMID: 33995636 DOI: 10.7150/jca.55173] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Zarębska I, Gzil A, Durślewicz J, Jaworski D, Antosik P, Ahmadi N, Smolińska-Świtała M, Grzanka D, Szylberg Ł. The clinical, prognostic and therapeutic significance of liver cancer stem cells and their markers. Clin Res Hepatol Gastroenterol 2021;45:101664. [PMID: 33667731 DOI: 10.1016/j.clinre.2021.101664] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ma Farag RM, Alayobi D, A Alsaleh K, Kwon H, El-ansary A, Dawoud EA. Influence of Glypican-3 as Anewly Diagnostic Biomarker in Earlydetection of Hepatocellular Carcinoma among Saudi Patients. Biomed Pharmacol J 2018;11:1789-96. [DOI: 10.13005/bpj/1550] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Wang QS, Shi LL, Sun F, Zhang YF, Chen RW, Yang SL, Hu JL. High Expression of ANXA2 Pseudogene ANXA2P2 Promotes an Aggressive Phenotype in Hepatocellular Carcinoma. Dis Markers 2019;2019:9267046. [PMID: 30881525 DOI: 10.1155/2019/9267046] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
11 Chen L, Li X, Wang H, Hou P, He H. Annexin A2 gene interacting with viral matrix protein to promote bovine ephemeral fever virus release. J Vet Sci 2020;21:e33. [PMID: 32233139 DOI: 10.4142/jvs.2020.21.e33] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Chen CY, Lin YS, Chen CH, Chen YJ. Annexin A2-mediated cancer progression and therapeutic resistance in nasopharyngeal carcinoma. J Biomed Sci. 2018;25:30. [PMID: 29598816 DOI: 10.1186/s12929-018-0430-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]